340 related articles for article (PubMed ID: 17406349)
1. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review.
Raza SA; Clifford GM; Franceschi S
Br J Cancer; 2007 Apr; 96(7):1127-34. PubMed ID: 17406349
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia.
Dondog B; Lise M; Dondov O; Baldandorj B; Franceschi S
Eur J Cancer Prev; 2011 Jan; 20(1):33-9. PubMed ID: 21166097
[TBL] [Abstract][Full Text] [Related]
3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Ka MM; Ndiaye MF; Herve P; Legueno B; Diop BM; Dangou JM; Niang A; Woto-Gaye G; Mendes V; Diop TM; Ndiaye PD; Bao O
Dakar Med; 1996; Spec No():59-62. PubMed ID: 14520992
[No Abstract] [Full Text] [Related]
5. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan.
Wang CS; Chang TT; Chou P
J Clin Epidemiol; 1998 Sep; 51(9):733-8. PubMed ID: 9731921
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
7. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and prevention of hepatocellular carcinoma.
Franceschi S; Raza SA
Cancer Lett; 2009 Dec; 286(1):5-8. PubMed ID: 19070421
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
11. Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan.
Lu SN; Chue PY; Chen HC; Wu MH; Chen IL; Huang JF; Wang JH; Peng CF; Shih CH; You SL; Lu CF; Chen CJ; Chang WY
J Gastroenterol Hepatol; 1997 Jul; 12(7):547-50. PubMed ID: 9257249
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia.
Hundie GB; Raj VS; GebreMichael D; Haagmans BL
J Med Virol; 2017 Jul; 89(7):1300-1303. PubMed ID: 28121005
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of hepatitis virus infection in hepatocellular carcinoma patients receiving surgical operation in China and Japan].
Yuan P; Tang W; Wen J; Li QM; Luo H; Liang BH; Zheng QM; Wei L
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Sep; 39(5):332-4. PubMed ID: 16266545
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C and B viruses, and their association with hepatocellular carcinoma in Egypt.
Darwish MA; Issa SA; Aziz AM; Darwish NM; Soliman AH
J Egypt Public Health Assoc; 1993; 68(1-2):1-9. PubMed ID: 7504048
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B and C in Egypt and Africa.
Attia MA
Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
Akcam FZ; Uskun E; Avsar K; Songur Y
Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
[TBL] [Abstract][Full Text] [Related]
17. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
de Martel C; Maucort-Boulch D; Plummer M; Franceschi S
Hepatology; 2015 Oct; 62(4):1190-200. PubMed ID: 26146815
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.
Donato F; Boffetta P; Puoti M
Int J Cancer; 1998 Jan; 75(3):347-54. PubMed ID: 9455792
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
